Similar articles

• What is graft versus host disease?

  van Bekkum DW. van Bekkum DW. Bone Marrow Transplant. 1991;7 Suppl 2:110-1. Bone Marrow Transplant. 1991. PMID: 1878668 Review. No abstract available.
• Graft-versus-host disease in the central nervous system. A real entity?

  Rouah E, Gruber R, Shearer W, Armstrong D, Hawkins EP. Rouah E, et al. Am J Clin Pathol. 1988 Apr;89(4):543-6. doi: 10.1093/ajcp/89.4.543. Am J Clin Pathol. 1988. PMID: 3281437
• Monoclonal anti-T cell (T12) antibody treatment of graft-versus-host disease in severe combined immunodeficiency: targeting of antibody and activation of complement on CD8+ cytotoxic T cell surfaces.

  Blomquist MD, Boggards M, Hanson IC, Rosenblatt HM, Pollack MS, Hawkins E, Ritz J, Shearer WT. Blomquist MD, et al. J Allergy Clin Immunol. 1991 May;87(5):1029-33. doi: 10.1016/0091-6749(91)90427-p. J Allergy Clin Immunol. 1991. PMID: 1902852
• Immunopathology of early graft-versus-host disease--a prospective study of skin, rectum, and peripheral blood in allogeneic and autologous bone marrow transplant recipients.

  Sviland L, Pearson AD, Green MA, Baker BD, Eastham EJ, Reid MM, Hamilton PJ, Proctor SJ, Malcolm AJ. Sviland L, et al. Transplantation. 1991 Dec;52(6):1029-36. doi: 10.1097/00007890-199112000-00018. Transplantation. 1991. PMID: 1836284 Clinical Trial.
• Graft-versus-host disease.

  Gatti RA, Kersey JH, Yunis EJ, Good RA. Gatti RA, et al. Prog Clin Pathol. 1973;5:1-18. Prog Clin Pathol. 1973. PMID: 4150104 Review. No abstract available.